Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Psychiatry. 2002 May;159(5):869-71.

Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?

Author information

1
Department of Psychiatry, University of California, San Diego, La Jolla, 92093-0810, USA. kcadenhead@ucsd.edu

Abstract

OBJECTIVE:

Subjects with schizotypal personality disorder demonstrate deficits in inhibition when assessed on prepulse inhibition, P50 suppression, and antisaccade paradigms. This study determined if distinct subgroups of subjects with schizotypal personality disorder could be identified on the basis of performance on these measures and whether endophenotypes could be defined for future genetic study by using measures of inhibitory function.

METHOD:

Prepulse inhibition, P50 suppression, and antisaccade paradigms were assessed in 21 subjects with schizotypal personality disorder.

RESULTS:

Seven subjects with schizotypal personality disorder had deficits on each paradigm; seven had no deficits on any paradigm. P50 and antisaccade deficits were present in five of the same subjects and significantly correlated.

CONCLUSIONS:

These results suggest that P50 and antisaccade performance reflects a common endophenotype and that prepulse inhibition identifies a separate endophenotype reflecting different neurobiological substrate(s) in subjects with schizotypal personality disorder. This pattern may generalize to schizophrenia spectrum disorder patients.

PMID:
11986147
DOI:
10.1176/appi.ajp.159.5.869
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center